Navigation Links
BMC receives National Institutes of Health grant to study intrauterine cocaine and substance reslience
Date:10/19/2010

(Boston) Deborah A. Frank, MD, the Director of the Grow Clinic for Children at Boston Medical Center (BMC) and a Professor of Pediatrics at Boston University School of Medicine (BUSM), has received a 5-year, $3.7 million grant from the National Institutes of Health to study the long-term impacts of intrauterine cocaine exposure (IUCE) and intrauterine substance exposure (IUSE).

The project, entitled Prenatal Cocaine Exposure: Young Adult Follow-Up, will examine resilience among young adults who had IUSE. Resilience evolves from person-environment interactions, which may buffer the impact of biologic and social risks.

The multidisciplinary, longitudinal study will look at 140-150 urban participants between the ages of 18- 24 who, along with their caregivers, have been monitored since birth for their exposure to violence and material hardship. The incarceration rates of participants' parents, exposure to discrimination, as well as the participants' ability to have a positive ethnic identity and quality young adult intimate relationships, have also been recorded.

Focusing on both environmental and biological factors, Frank and her colleagues will analyze the resilience of the participants and their ability to beat the odds despite negative circumstances.

"Many Americans have experienced intrauterine exposures to psychoactive substances, which may put them at an increased risk for difficult life circumstances," said Frank, principal investigator on this grant. "We are working to identify the factors that can foster resilience, which could yield important public health interventions."


'/>"/>

Contact: Jenny Eriksen
jenny.eriksen@bmc.org
617-638-6841
Boston University Medical Center
Source:Eurekalert

Page: 1

Related biology news :

1. Wistar Institute researcher receives New Innovator award from NIH
2. L-1 Identity Solutions Receives $5.9 Million Drivers License Contract Expansion from the State of Mississippi
3. Kount Receives Patent for Device Fingerprinting
4. American College of Medical Genetics receives $13.5M NIH contract
5. Penn State receives new NASA astrobiology grant
6. Global Viral Forecasting Initiative receives $11M to implement pandemic early warning system
7. Vidaza receives positve opinion from European CHMP
8. Case Western Reserve receives Ellison Medical Foundation New Scholar in Aging award
9. Montana State partnership receives $66.9M for carbon sequestration
10. Oklahoma EPSCoR receives $20 million for biofuels research
11. UC Riverside rice geneticist receives high honor from US Department of Agriculture
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/9/2016)... UAE, May 9, 2016 Elevay ... comes to expanding freedom for high net worth professionals ... in today,s globally connected world, there is still no ... could ever duplicate sealing your deal with a firm ... passports by taking advantage of citizenship via investment programs ...
(Date:4/28/2016)... and BANGALORE, India , April 28, 2016 ... a product subsidiary of Infosys (NYSE: INFY ), ... a global partnership that will provide end customers ... mobile banking and payment services.      (Logo: ... innovation area for financial services, but it also plays a ...
(Date:4/26/2016)... LONDON , April 26, 2016 ... EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... a partnership to integrate the Onegini mobile security ... (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The ... enhanced security to access and transact across channels. ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... , June 23, 2016   EpiBiome , a ... $1 million in debt financing from Silicon Valley Bank ... automation and to advance its drug development efforts, as ... facility. "SVB has been an incredible strategic ... services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... ... 2016 , ... STACS DNA Inc., the sample tracking software company, today announced ... has joined STACS DNA as a Field Application Specialist. , “I am thrilled ... COO of STACS DNA. “In further expanding our capacity as a scientific integrator, Hays ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
(Date:6/23/2016)... LONDON , June 23, 2016 ... & Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... Review , the peer-reviewed journal from touchONCOLOGY, ... the escalating cost of cancer care is placing ... a result of expensive biologic therapies. With the ...
Breaking Biology Technology: